Osteoporosis and Bone Disorders

Top Story

VIDEO: Intra-articular sprifermin prevented cartilage loss in patients with knee OA

November 14, 2017

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Marc C. Hochberg, MD, spoke about a study that evaluated the efficacy and safety of intra-articular sprifermin in patients with symptomatic radiographic knee osteoarthritis. When sprifermin was administered at a higher dose at 6 months or 12 months it slowed progression of joint space loss or cartilage thinning and was associated with an increase in cartilage thickness.

In the Journals

Lifetime risk for total hip replacement increases in 5 countries

November 13, 2017
In five countries during a 10-year period, there have been statistically significant increases in the lifetime risk for total hip replacement surgery for…
In the Journals PlusPerspective

Air pollution may increase osteoporosis-related bone fracture risk

November 9, 2017
Adults, particularly those with a low income and aged at least 65 years, have an increased risk for bone fracture and osteoporosis-related loss of bone mineral density…
Meeting NewsVideo

VIDEO: Women with osteoporosis had reduction in vertebral, nonvertebral fractures with abaloparatide, alendronate

November 8, 2017
SAN DIEGO — At the American College of Rheumatology Annual Meeting, Robin K. Dore, MD, spoke about results of the ACTIVExtend trial of postmenopausal women with…
More Headlines »
CME

Hip Resurfacing Implants: August 2015

Hip resurfacing offers a suitable solution for young patients affected by hip disease who have high function demands…
More »
Video
Meeting News

VIDEO: Intra-articular sprifermin prevented cartilage loss in patients with knee OA

November 14, 2017
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CME

The Role of the Inflammatory Cascade in the Pathogenesis and Treatment of Psoriatic Arthritis: New and Emerging Therapies

This activity is supported by educational grants from Celgene Corporation and Novartis Pharmaceuticals Corporation.

The workings of the inflammatory cascade are not fully defined, but recent findings have demonstrated roles for novel…
More »
Advertisement
Advertisement